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Polyethylene oxide matrix tablet swelling evolution: 
The impact of molecular mass and tablet composition
This article describes the designing of matrix tablets com-
posed of polyethylene oxides (PEOs) with relative molecu-
lar masses of 1 × 106, 2 × 106, and 4 × 106. Percolation thres-
holds were determined for all of the selected PEO 
formulations (18, 16, and 12 %, m/m), taking into considera-
tion excipients and tablet surface area which significantly 
increased the percolation threshold. Moreover, the robust-
ness of the gel layer in PEO matrix tablets was evaluated by 
magnetic resonance imaging under various mechanical 
stresses (no flow, 12 mL min–1, and 64 mL–1 of medium 
flow). Correlations between the percolation threshold and 
gel thickness (R2 = 0.86), gel thickness and the erosion coef-
ficient (R2 = 0.96) was detected. Furthermore, small-angle 
X-ray scattering of the selected PEOs detected differences 
in polymer molecular complexity at the nanoscale. Finally, 
the ratio of the heat of coalescence to the heat of fusion has 
confirmed the PEO molecular mass-dependent percolation 
threshold.
Keywords: polyethylene oxide, MRI, percolation threshold, 
SAXS, WAXS
Hydrophilic matrix tablets are the most commonly used drug delivery systems for 
extended drug release with zero-order release kinetics, which sustain constant in vivo 
plasma concentrations. High relative molecular mass (Mr) polyethylene oxides (PEOs) are 
non-toxic, non-ionic, water-soluble polymers used in the development of controlled deli-
very systems (1–3). Due to their hydrophilic character, PEOs swell upon contact with body 
fluids. During hydration, a gel layer is formed around the tablet core, generating a fluid 
diffusion barrier and simultaneously restricting drug diffusion into the medium. With 
increasing polymer Mr, a thicker and more robust gel is formed, resulting in a slower dis-
solution and higher resistance of the gel layer to mechanical stresses (1, 2). The polymer 
swelling rate depends on molecular characteristics (chain length, the radius of gyration, 
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and consequently their swelling rate (4). The PEO polymer swelling properties also  depend 
on the number and types of interactions in an aqueous environment that determine the 
connections between polymer chains and therefore viscosity, swelling, and gel forma-
tion (5–7). The effect of the morphology of hydrated drug-loaded polymer matrices on 
erosion, drug release, and degradation is well described (8) and mainly depends on the 
ratio of hydrophobic and hydrophilic domains in the molecular structure (9, 10). More-
over, the difference in PEO crystallinity is reflected in various lamellar thicknesses, and 
this generally impacts the burst effect upon drug release (11, 12).
As a state-of-the-art variable, different excipients can change polymer hydration. 
The literature explains how the hydration of PEG-containing copolymers (13), their 
structure (14), and the clustering of water in polymers (15) affect drug release and poly-
mer resorption. The disruption of polymer chains is caused by the interactions between 
water molecules and polymer chains, which can result in phase separation of the poly-
mer domains and a faster drug release. To ensure constant controlled drug release, the 
gel thickness in hydrophilic matrix systems should be unsusceptible to applied mecha-
nical stresses. This can be attained with polymer concentrations above the percolation 
threshold (i.e., the concentration that ensures the formation of a uniform and robust gel 
layer around the tablet core). Percolation threshold concentrations have been extensively 
studied in hydroxypropyl methylcellulose (HPMC) formulations (16–20), but not for 
PEOs with Mr of 1 × 106, 2 × 106, and 4 × 106. Therefore, for the successful development of 
matrix tablets with constant drug release, the impact of different excipients on the swell-
ing process should be well understood.
Nuclear magnetic resonance (NMR) and magnetic resonance imaging (MRI) are 
used as non-invasive approaches for investigating gel formation upon polymer hydra-
tion with improved measurement precision (21–24). Moving front positions and polymer 
concentration in the gel layer during tablet hydration are characterized by T2-mapping 
(25), T1-weighted (26, 27), and diffusion-weighted (28) MRI methods. This also allows the 
simultaneous measurement of the gel formation and the drug release either by a combi-
nation of 1H and 19F MRI (29–31) or by using a flow-through cell with a combination of 
MRI and UV-VIS spectrometry (32).
Only a few studies of MRI applications in research on PEO matrix tablets and effects 
of composition (27, 28) and mechanical stresses (1, 3, 33) on their gel thickness have been 
reported separately, without a focus on microstructural polymer characteristics.
The objective of this study is systematic, qualitative, and quantitative determination 
of molecular differences between selected PEOs with Mr of 1 × 106, 2 × 106, and 4 × 106. 
Wide-angle X-ray scattering (WAXS) and small-angle X-ray scattering (SAXS) were ap-
plied to detect the differences in microstructures (polymer molecular dimension, size, 
structure, crystallinity, and pore sizes) of selected PEO polymers. DSC and hot-stage 
optical microscopy were used to gain better insight into the polymer structure. To con-
firm the differences detected at the microscopic level, MRI was used with the addition 
of detecting moving fronts in the PEO prolonged-release tablets (PRTs). The study also 
includes the impact of formulation composition as well as the mechanical stress effect 
on gel formation and drug release. Ultimately, a separate percolation threshold study 
was performed on selected PEO PRTs using binary and multicomponent systems in 
 order to elucidate how the tablet’s shape and composition affect the PEO percolation 
threshold.
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Three different Mr of PEO (PolyoxTM, Dow-Colorcon, Dartford, UK) were used: low 
(1 × 106), medium (2 × 106), and high (4 × 106). The model drug with Mr of 397 Da and low 
apparent permeability (BCS class III) was used. Its calculated dose/solubility volume is less 
than 15 mL in aqueous buffer solutions, with a physiological pH range from 1 to 7.5. The 
model drug structure has four hydrogen bond donors and six hydrogen bond acceptors. 
All other chemicals and solvents were of analytical grade and were used without further 
purification. The reagents NaOH, KH2PO4, and H3PO4, used for the dissolution testing and 
HPLC assay, were purchased from Merck, Germany. Acetonitrile was obtained from J. T. 
Baker, US. For all experiments, a medium phosphate buffer with a pH of 6.8 was used 
throughout the study, prepared with deionized water.
SWAXS analysis of the selected PEOs
The nanostructures and crystallinity of three PEOs were analyzed using simultane-
ous small- and wide-angle X-ray scattering (SWAXS). SWAXS measurements were per-
formed using an S3-MICRO SWAXS system (Bruker AXS, formerly Hecus X-ray Systems, 
Austria) featuring a Cu Kα X-ray microsource (Xenocs, France) with point-focusing optics. 
Samples were contained in X-ray capillaries with a 1.5 mm inner diameter and rotated 
during exposure at ≈0.2 Hz in a temperature-controlled cuvette (TCCS and SpinCap, 
Hecus). Exposure times were generally 5 min/sample. Scattering signals were simultane-
Table I. PEO test formulations (TF) containing PEOs with different molecular masses, polyethylene glycol 
(PEG), other excipients and model drug belonging to class III of biopharmaceutical classification system (BCS)
TF
Composition (%) 1 2 3 4 5 5b 6 6a 6b 6c 7 7b
Low-Mr PEO 100 27 27
Intermediate-Mr 
PEO 100 38.5 27 23 27 35
High-Mr PEO 100 27 27
PEG 61.5 48 52 48 40 48 48
Other excipients 




Model drug (BCS 
III) 20
Tablet shape round round oval round oval round oval
Tablet surface 
area (mm2) 309 309 196 309 196 309 196
218
P. Draksler et al.: Polyethylene oxide matrix tablet swelling evolution: The impact of molecular mass and tablet composition, Acta 
Pharm. 71 (2021) 215–243.
 
ously detected in the SAXS (0.06–8° 2θ) and WAXS (17–27° 2θ) regions by two linear posi-
tion-sensitive detectors (Hecus PSD-50). The fractal dimensions (Ds) were derived from 
the slope in the double-logarithmic SAXS-plots (34). The WAXS profiles were used to ob-
tain information on the relative degree of crystallinity in the semi-crystalline PEO systems 
based on the Bragg peaks characteristic of PEOs. Furthermore, Micro-DSC analysis of the 
PEO powders was performed using MicroCalix (Setaram, France). A complementary set of 
thermal analyses was performed using polarized hot-stage optical microscopy from room 
temperature to 200 °C at a heating rate of 2 °C min–1.
Formulation of PEO PRTs
Test formulations (TF) 1–4 were prepared using manual sieving, mixing, and com-
pression to form round 250 mg tablets with a 12 mm diameter or oval 250 mg tablets (Table 
I). Moreover, samples of pure PEO polymers were prepared (TF 1–3) and TF of medium- Mr 
PEO with the addition of PEG with Mr of 8000 (TF 4) as well as with variation of PEG 8000 
addition (TF 6a–c). The coating effect on drug release and swelling properties was evalu-
ated at the beginning of the study.
Preparation of PEO binary systems
For the percolation threshold study, several binary mixtures of selected PEO polymers 
and the model drug in different mass concentration ranges were prepared (Table II, TFs 
X–Z) in order to determine the critical polymer concentration for the formulation of a 
 robust hydrogel. Blends were then compressed into 250 mg round 12 mm tablets. A drug 
release study was conducted using the dissolution method described in section Drug 
 release study from PEO PRTs below using a standard paddle apparatus (Apparatus II,  VanKel 
Dissolution Apparatus, model VK 7000, USA).
Preparation of reference PEO gel samples
Gels with a polymer mass ratio (m/m) ranging from 1 to 100 % of all selected PEOs 
were prepared using purified water and a potassium phosphate buffer with a pH of 6.8. 
Various gel preparation approaches were used: i) for PEO concentrations between 1 and 
30 %, PEO with a selected Mr was weighed and dispersed in the selected medium with a 
magnetic stirrer until a uniform gel was formed; ii) for gel concentrations between 30 and 
50 % polymer, PEO with a selected Mr was placed in a desiccator with salts of defined 
relative humidity and equilibrated; iii) For PEO concentrations higher than 50 %, a prede-





X 1 × 106 10–90 X10–X90
Y 2 × 106 10–90 Y10–Y90
Z 4 × 106 10–90 Z10–Z90
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termined amount of medium was added to PEO powder with a selected Mr in the sealed 
beaker and equilibrated; iv) for 100 % PEO samples, PEO powder was dried in a vacuum 
dryer to absolute dryness at 60 °C.
PEO gels NMR relaxation times
For gels of known PEO concentration in both media (water and a potassium phos-
phate buffer with a pH of 6.8), the NMR spin-lattice (T1) and spin-spin (T2) relaxation times 
were measured at room temperature and at a 1H NMR frequency νH = 100 MHz. Tecmag 
Apollo (Tecmag, USA) an MRI spectrometer with a superconducting 2.35 T horizontal bore 
magnet (Oxford Instruments, UK) equipped with gradients and RF coils for MR micros-
copy (Bruker, Germany) was used for the experiments. A standard inversion recovery 
sequence (35) (180° − τ − 90° − AQ) by changing τ values from 0.02 ms to 15 s was used to 
measure the T1 time. The T2 times of gels with polymer concentrations lower than 80 % 
were measured using a CPMG pulse sequence (9) (90° − τ − (180° − τ − AQ-τ)N) with τ = 1 
ms and N = 3,000. For samples at higher PEO concentrations (> 80 %) with short T2 (T2 < 5 
ms), the T2 times were measured by a Hahn echo pulse sequence by changing the inter-
echo time from 0.02 ms to 2 s.
MRI of swelling PEO PRTs
The tablet for MRI was inserted into a container so that only one cylinder base was 
exposed for the medium penetration. After 10 minutes of tablet swelling the first MR 
 image was taken and then every 30 minutes for 15 hours.
The same spectrometer as used for the relaxation time measurements was used to 
record the MRIs at room temperature. Two different MRI methods were used in order to 
determine the erosion, swelling, and penetration front positions upon tablet swelling. To 
measure the positions of the erosion and swelling fronts, a 2D T1-weighted MRI was taken 
using a standard spin-echo pulse sequence (35) with echo time (TE) of 6.2 ms and repeti-
tion time (TR) of 200 ms. The field of view was 50 mm with an in-plane resolution of 200 
µm and a slice thickness of 3 mm. A one-dimensional single point imaging (1D SPI) 
 sequence was used to detect the medium penetration into the tablet. A single point on the 
free induction decay was sampled at encoding time tp = 0.17 ms after the radiofrequency 
detection pulse α = 20° with TR of 200 ms with a resolution of 350 µm.
The MRI experiments were repeated with the flow-through cell in order to determine 
the gel thickness during swelling and drug release under the same conditions. A con-
tainer with 900 mL of medium was connected to a homemade MRI flow-through cell using 
plastic tubes. The medium flow was driven by a peristaltic pump (Anko, USA) and con-
trolled at two different flow rates: 12 ± 2 and 64 ± 2 mL min–1. Because the MR images were 
acquired during flow, motion artefacts were observed in the area where only the medium 
was present. On the other hand, no artefacts were observed in the gel because the gel was 
hard enough so that the flow did not provoke large gel movements. This was confirmed by 
comparing the two consecutive images, first without flow and immediately thereafter with 
the flow, and the same gel thicknesses were determined from both images.
The measurements were repeated at least three times for each kind of experimental 
setting and tablet.
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Drug release study from PEO PRTs
Drug release from PEO PRTs was evaluated with a “non-mixing” (static) and “mixing” 
(dynamic) method during MRI measurements and with the standard paddle method (USP 
Apparatus 2, with three repetitions n). The standard paddle method was performed on a 
fully calibrated dissolution apparatus (Apparatus II, VanKel Dissolution Apparatus,  model 
VK 7000, USA) with a paddle speed of 50 rpm, temperature 37 ± 0.5 °C, and 900 mL of 
medium phosphate buffer with a pH of 6.8. At predetermined time intervals, 1.7 mL 
 samples were withdrawn without being replaced.
To study drug release using the “non-mixing” method, tablets were inserted into the 
same containers as for MRI measurements. Medium penetration was allowed from only 
one circular surface, with no medium mixing. Ten containers with each type of tablet 
(Table I) were prepared and 5.2 mL of the medium was added to all containers at the same 
time. The medium was removed from one of the containers at the same time points as for 
the paddle method, and drug content was determined as described above. Additionally, 
drug release was measured with the “mixing” method. Here the medium flow was used 
at two different flow rates (i.e., 12 ± 2 and 64 ± 2 mL min–1) to study the influence of mecha-
nical stress on drug release. The 5 mL samples were withdrawn without being replaced 
from the 900 mL container at predetermined time intervals.
The collected samples were filtered through a filter with 1.0 µm pores and analyzed 
using HPLC, with UV detection at a wavelength of 249 nm (Agilent 1100Series Agilent 
Technologies, Germany). An XTerra column C18 3.5 µm (150 × 4.6 mm; Waters, USA) was 
used. The mobile phase represented the mixture of phosphate buffer (pH 4.0) and aceto-
nitrile in a 1:3 ratio, respectively. The fraction of drug release Q =  was plotted as the function 
of time, where mt is mass of the drug released at time t and m∞ is mass of the drug that can 
be released at infinite time, and thus is considered equal to the drug loading in the tablet.
Determination of the erosion and diffusion contributions to drug release
A semi-empirical model developed by Narasimhan and Peppas was used to deter-
mine erosion and diffusion contributions to drug release (36). The model considers two 
moving boundaries: the swelling front R and the erosion front S, and it defines the gel 
layer thickness as S−R. A steady-state solution to the model equations gives the depen-
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where l is the tablet thickness, and vdeq and vd* are the drug equilibrium volume fractions 
at gel-medium interface S and at glassy-gel interface R, respectively. To be able to describe 
the experimental data, the delay time t0 was added to Eq. 2. Namely, at higher flow rates, 
larger pieces of the gel can be removed from the gel layer and the drug cannot be immedi-
ately released into the medium because of the large size of the torn pieces. The term A 
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The term B describes chain disentanglement and dissolution leading to Case II trans-









where D1 and Dd are the diffusion coefficients of the medium and drug, respectively. v1* 
and v1eq are the medium equilibrium volume fractions at interface S and at interface R, 
respectively, and kdis is the disentanglement rate of the polymer chains, which can be 
given as the ratio of the radius of gyration rg and the reptation time trept, kdis = rg/trept. Eq. 2 
can be simplified by defining the diffusion rate constant  and the erosion rate constant . 
The kd and kr can be used to calculate the diffusion (D) and erosion (E) contributions to 



































Estimation of the percolation threshold
To determine the percolation threshold for PEO polymers with the selected Mr drug 
release from PEO, binary PRTs (Table II) were evaluated with the standard paddle method 
(Apparatus II, VanKel Dissolution Apparatus, model VK 7000, USA, n = 3) as described in 
section Drug release study from PEO PRTs. The polymer percolation threshold was defined 
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as the concentration of polymer in the matrix tablet at which drug release kinetics change 
significantly.
Drug release profiles were analyzed using the Higuchi equation 7 (38) and Korsmey-
er-Peppas equation 8 (39):
 Q = kH t1/2  (7) 
 
 Q = k tm  (8)
where kH and k are kinetic constants; m is an exponent indicating the release mechanism: 
m = 0.5 indicates diffusion-controlled drug release and m = 1.0 indicates relaxation-erosion-
controlled drug release. Values between 0.5 < m < 1.0 indicate an anomalous (non-Fickian 
or both diffusion/relaxation) controlled drug release.
Similarity factor calculation
The drug release profiles of selected binary systems (TF X18, TF Y16, TF Z12 and TF 
X20, TF Y20, TF Z20) were compared using a similarity factor ( f2), using Eq. 9. The number 
of dissolution sample times is sampled as n, and Rt represents the percent of drug dis-
solved in the reference at each sample point t and Tt in the test product. The drug release 
profiles of the two dissolution profiles are similar if f2 ≥ 50 and dissimilar if f2 < 50.
 




























t t  (9) 
Statistical data analysis
The reported values are means with standard deviations of experiments with at least 
three repetitions. A one-way analysis of variance (t-test) was used to analyze data and p < 
0.05 was considered as significant.
RESULTS AND DISCUSSION
Effect of tablet composition on gel relaxation times
The relaxation times T1 and T2 were studied in: i) gels at known polymer concentra-
tions of pure PEO polymers with three different Mr (low, medium, and high: TFs 1, 2, 3); ii) 
a mixture of medium- Mr PEO and PEG (TF 4); iii) pure PEG; and iv) a mixture of medium- 
Mr PEO, PEG, model drug, and other excipients (TF 6). The gels were prepared with puri-
fied water and a potassium phosphate buffer with a pH of 6.8. No differences between the 
relaxation times measured in gels prepared with water or potassium phosphate were ob-
served, and therefore only the results of the relaxation times in gels prepared with a potas-
sium phosphate buffer with a pH of 6.8 are shown in Fig. 1. At polymer concentrations 
below 80 %, two lines with mono-exponential T1 decay occurred, whereas at higher poly-
223
P. Draksler et al.: Polyethylene oxide matrix tablet swelling evolution: The impact of molecular mass and tablet composition, Acta 
Pharm. 71 (2021) 215–243.
 
mer concentrations one broad line with a double-exponential T1 decay was detected in the 
NMR spectra (data not shown). Different Mr or the presence of the excipients did not have 
any effect on T1 values (TFs 1–6). A decrease in T1 was observed when polymer concentra-
tion increased, exhibiting a minimum at cpol ≈ 80 %, and increasing at higher concentra-
tions (Fig. 1a).
The decay curves for T2 values were double-exponential. Both components of T2 de-
creased with increasing polymer concentration, and the decrease became significantly 
steeper at concentrations higher than 80 %. The T2 decrease was the consequence of more 
restricted proton mobility in gels with higher polymer concentrations. No differences 
among T2 values were observed among the different Mr, except for the gels containing 
PEO, PEG, model drug, and other excipients (TF 6), for which T2 values were significantly 
shorter (Fig. 1b).
MRI was used to visually and quantitatively monitor changes during tablet swelling. 
Penetration, swelling, and erosion fronts were evaluated using two different MRI  methods: 
a 1D SPI pulse sequence was applied to determine medium penetration into the tablet and 
a 2D T1-weighted spin-echo sequence to resolve the swelling front (the border between 
hydrated polymer in a glassy state and the gel) and erosion front (the border between the 
gel and bulk medium). The 2D spin-echo images at different swelling times for low-Mr 
PEO are shown in Fig. 2a. The relaxation times T1 and T2 change with polymer concentra-
Fig. 1. Relaxation times (solid symbols): a) T1 and b) T2 for gels at different polymer ratios cpol (m/m) × 
100 % for TF 1, TF 2, TF 3, TF 4, TF 6, and PEG only in a potassium phosphate buffer with a pH of 6.8. 
Lines denote the position of T1 minimum and the break in the T2 slope.
a)                                                 b)
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tion (Fig. 1), resulting in different signal intensity of gels with different polymer concentra-
tions, which are seen as different MRI brightness. The dry tablet core was black on the MRI 
due to too short T2 of dry polymer. As the amount of medium in the gel increased, the T2 
became longer, resulting in a brighter image. On the other hand, the medium signal was 
not very bright due to the long T1 and the use of the T1-weighted spin-echo pulse sequence. 
The erosion and swelling fronts were determined from the signal intensity of 2D T1-
weighted spin-echo images. As can be seen from the T2 concentration dependence (Fig. 1b), 
Fig. 2. a) MRI of TF 1 during swelling (left column without flow and right column with the flow of 64 
mL min–1), TF 1, TF 2, TF 3, and TF 4; b) erosion, swelling, and penetration fronts; c) gel layer thickness 
without flow (solid symbols) and with 64 mL min–1 flow (open symbols).
a)  
b)                                                                c)
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the T2 steeply drops at phase transition from the glassy state to the gel state. The T2 value 
of concentrated gel just before the transition to the glassy state (T2 > 100 ms) is long enough 
to produce the spin-echo signal. In the glassy state, the T2 is much shorter (T2 < 1 ms) and 
no spin-echo MRI signal was observed. Therefore, the swelling front was determined at 
the position where the signal intensity vanishes and the erosion front at the position where 
the signal intensity starts to increase above the signal of the bulk medium. The penetration 
front was determined from the SPI signal intensity profile at the position where 1D SPI 
signal intensity increased above the signal intensity of the dry tablet core. The gel thick-
ness was calculated as the difference between the erosion and swelling fronts.
Effect of PEO M on gel thickness under no-flow conditions
First, the effect of the selected PEO on the swelling properties was investigated (Figs. 
2b,c) under no-flow conditions. The differences in the penetration front between PEOs 
were noticed. Medium penetration is faster in high-Mr PEO (TF 3; Fig. 2b), supporting lite-
rature data on faster water penetration into the matrix system due to its lower crystallinity 
(3). In the case of medium (TF 2) and low (TF 1) Mr PEOs there is higher crystallinity, 
 preventing water from penetrating through the matrix system (11), and therefore the pene-
tration is slower.
The swelling rate is independent of Mr, but some differences in erosion among different 
relative molecular masses have been observed. Erosion front expansion was slightly  slower 
in the PEO with the lowest Mr (TF 1), resulting in a slightly thinner gel layer, especially at 
longer swelling times. The thinner gel layer in TF 1 results from the formation of a softer 
gel layer, which is more sensitive to erosion (2, 33). On the other hand, the gel layer in PEO 
tablets with higher Mr values (TFs 2 and 3) forms a gel less susceptible to erosion, resulting 
in a thicker gel layer (1, 3, 33).
Effect of medium flow on gel thickness
The effect of the medium flow on polymer swelling and gel erosion under mechanical 
stress, which is expected to be present under the in vivo conditions during tablet swelling, 
was studied for all three PEOs. The 2D spin-echo images of TF 1 containing the PEO with 
the lowest Mr during swelling with the highest medium flow of 64 mL min–1 are shown in 
Fig. 2a. The medium signal was distorted owing to medium flow and consequently the 
movement of the medium during signal acquisition. On the other hand, the gel signal was 
undistorted because the gel was hard enough that the flow did not cause gel movement to 
such an extent that movements would cause image artefacts.
The data, thus, show that erosion front expansion drastically decreases when a  medium 
flow of 64 mL min–1 is applied to the PRTs, whereas the penetration and swelling fronts are 
not affected by the flow. Differences in the gel thicknesses measured under different 
 mechanical stress conditions increase with swelling time (Fig. 2c).
The largest effect of the flow was observed in TF 1 with the lowest Mr, for which signi-
ficantly thinner gel (≈ 5 mm) was formed from the early beginning of the test (1 h)  compared 
with the gel thickness of the same tablets swelling under the no-flow condition (≈ 9 mm). 
Under stress conditions, the tablet completely disintegrated after 8 h (Fig. 2c). The differ-
ences in the gel thicknesses measured with and without flow were still significant but 
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smaller for the medium-Mr formulation (TF 2), for which the gel thickness was the same 
for the first 4 h and became thinner (≈ 7 mm) at later times compared to the gel thickness 
measured without flow (≈ 9 mm). An insignificant difference was observed for the PEO 
with the highest Mr (TF 3), for which the gel became only slightly thinner after 10 h (≈ 8 
mm; Fig. 2c). Moreover, compared to low-Mr PEO, TF 2 and TF 3 did not disintegrate during 
the test (12 h), showing a significant difference in gel layer strength.
At a flow rate of 64 mL min–1, the thinnest gel was formed during swelling of PEO 
with the lowest Mr followed by medium-Mr PEO, and the thickest gel was formed during 
swelling of PEO tablets with the highest Mr. The results thus demonstrate that consistency 
of the gel layer depends on PEO Mr and that at applied mechanical stress the gel robust-
ness increases with increasing Mr, supporting literature findings (1, 3, 40, 41).
Effect of PEG addition on gel thickness
To evaluate the impact of PEG on the swelling behavior of tablets composed of medium- 
-Mr PEO, TF 4 was used (Table I). Under static conditions, no significant differences 
 between swelling properties of pure medium-Mr PEO tablets (TF 2) and tablets with added 
PEG (TF 4) were observed in the first 10 h of swelling (after 4 h the swelling of the TF 4 
tablets was slightly faster). However, after 10 h, the erosion of the TF 4 tablets had in-
creased, resulting in a decrease of the gel thickness in contrast to pure medium-Mr PEO 
(TF 2) tablets, for which the gel thickness increased up to 12 h (Fig. 2c). The impact of PEG 
on gel layer characteristics is even more pronounced when the gel thickness was measured 
with the medium flow. When mechanical stress was applied, the gel layer was signifi-
cantly thinner (≈ 3 mm) than in TF 2 tablets (≈ 7 mm), and the tablet started to disintegrate 
after 7 h (Fig. 2c). Moreover, the gel layer thickness also decreased when compared to gel 
thickness under static conditions (≈ 9 mm). The observed impact of the PEG is expected 
because the hydration of the pure PEG tablets in the medium was very fast and the tablet 
almost immediately disintegrated (data not shown). The results thus support and visua-
lized the data regarding PEG chain domains, which are the same size as water, and there-
fore they work as a gel-enhancing agent, resulting in enhanced hydration and formation 
of a softer gel layer, which is more sensitive to erosion (27).
Effect of tablet composition on gel thickness
No-flow conditions
To evaluate the effect of PRT composition on gel thickness and swelling kinetics of 
PEO polymers representing a more realistic case in the development of PRTs, PEO poly-
mers with selected relative molecular masses, model drug, PEG, and other excipients were 
formulated (TFs 5–7; Table I). Fig. 3a shows that for the lowest Mr PEO formulation (TF 5) 
the gel layer thickness increased with time and was only slightly thinner (< 1 mm) for the 
first 5 h than in pure polymer tablets with the same Mr (TF 1). After 5 h, the gel thickness 
in TF 1 has continuously increased to form an approximately 9 mm gel layer, whereas the 
gel layer thickness of TF 5 became thinner (≈ 5.5 mm) but constant after 6 h, showing that 
the rate of erosion and swelling was the same (Fig. 3a). Surprisingly, no differences in the 
gel layer thicknesses for the medium and the highest Mr PEO tablets without and with 
excipients were observed until 10 h, and after that, only a small reduction of the gel thick-
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ness (≈ 1 mm) was detected. The results thus showed that the gel layer thicknesses do not 
significantly decrease when excipients are added to medium and high-Mr PEO polymers 
when no mechanical stress is applied. In low-Mr PEO, the gel layer reduction is significant, 
even under no-flow conditions.
Flow conditions
The effect of the addition of the excipients to PEO PRT was even more pronounced 
under flow conditions (Fig. 3b), confirming literature data (2, 33, 40). At the flow rate of 64 
mL min–1, the greatest differences in gel layer thicknesses between tablets of the lowest Mr 
pure PEO (TF 1) and tablets of PEO with added excipients (TF 5) were observed. Gel thick-
Fig. 3. Gel layer thicknesses for TFs 1–3, TF 4 (circles), and TFs 5–7 (squares). a) no flow; b) 64 mL 
min–1 medium flow; c) comparison between the gel layer thicknesses without flow, with the flow of 
12 mL min–1, and with the flow of 64 mL min–1 for TF 4, TF 5, TF 6, and TF 7.
a)                                                                    b)
c)
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nesses of pure polymer (TF 1) and polymer formulation with excipients (TF 5) were the 
same for the first 3 h (≈ 3 mm). After that, the gel disintegration in TF 5 had increased with 
time, and the tablet had completely vanished after 5 h. On the other hand, in TF 1 the gel 
layer thickness had increased constantly up to 8 h. Similar differences were observed for 
medium-Mr PEO containing excipients (TF 6), for which the gel layer was significantly 
thinner (≈ 3.5 mm) compared to the gel layer (≈ 7 mm) of the pure polymer (TF 2) and 
started to degrade after 5 h. For the highest Mr PEO formulation with excipients (TF 7), the 
gel layer was also thinner (≈ 4 mm) than in TF 3 of the pure polymer (≈ 7 mm), and its 
degradation started at approximately 8 h of swelling, whereas no gel degradation was 
observed in TF 3 at least for 12 h. The results confirmed that the addition of excipients into 
PRTs causes the formation of a more sensitive gel layer, which is more susceptible to ero-
sion compared to PRT with pure polymer, regardless of polymer Mr.
For the medium-Mr PEO, the impact of PEG only on the swelling was also studied. 
Differences in the gel thicknesses between TF 6 (containing the drug and other excipients) 
and TF 4 (containing only medium-Mr PEO and PEG) were also observed. TF 6 degraded 
faster than TF 4. This shows that not only PEG but also other water-soluble additives en-
hance water penetration into PRT, disrupting intra-polymer interactions and enhancing 
the disentanglement of polymer chains, leading to faster erosion of PRT and consequently 
drug release (42), although the effect of the drug and other excipients was found to be 
much smaller than the effect of PEG. This supports prior reports that at a high PEG:PEO 
ratio erosion of the gel layer is determined by PEG concentration (27).
Additionally, the influence of mechanical forces (dynamic conditions) on gel layer 
thickness for TFs 4–7 was studied using two different flow rates: 12 and 64 mL min–1 (Fig. 
3c). In all cases, the gel layer thickness decreased with an increased flow rate due to en-
hanced erosion of PRTs. In the formulation with the lowest Mr PEO (TF 5), the gel thickness 
and the start of the erosion process correlate with the flow rate. Higher flow induces  greater 
mechanical forces on the gel layer, causing faster degradation of the tablet compared to the 
lower flow, although the swelling rate for the first 2 hours was not affected. Moreover, for 
the medium-Mr formulation (TF 6), a 64 mL min–1 flow rate significantly increased matrix 
tablet degradation and the gel erosion process (5 h), whereas a 12 mL min–1 flow was not 
strong enough to cause the total degradation of the gel layer formed. A constant thick gel 
layer of approximately 3.5 mm was formed at 12 mL min–1 flow, showing a synchronized 
swelling and erosion process. Nevertheless, polymer (TF 7) with the highest-viscosity 
formed an approximately 8 mm thick gel resistant to mechanical stress caused by a flow 
of 12 mL min–1; that is, the gel thickness was approximately 1 mm thinner compared to the 
gel thickness measured under the no-flow condition. When the flow rate was increased to 
64 mL min–1, gel erosion increased, resulting in a significantly more pronounced erosion 
process ending in a significantly thinner gel layer (≈ 4 mm) and total disintegration of the 
tablet after 7 h.
It can, therefore, be concluded that after the addition of PEG, drug, and other excipi-
ents (TFs 4–7) to pure polymers (TFs 1–3) the gel thickness significantly decreases, which 
is even more pronounced under stress conditions. The most robust gel is formed with the 
highest Mr PEO (TF 7, Fig. 3b), confirming again that with increased Mr the gel layer con-
sistency also increases due to a tighter connection between polymer chains. When only 
PEG was added to polymer (TF 4), the erosion process at a higher flow rate started 3 h 
later than in TF 6, confirming that other hydrophilic excipients (43) and the drug itself (44) 
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also enhanced hydration of the matrix system. It is interesting to note that the swelling rate 
is the same for all formulations with added PEG or other excipients (TFs 4–7), but erosion 
is different and consequently, the tablet degradation depends on PEO’s Mr (Fig. 3b). This 
shows that for the PEG-to-PEO ratio used, the erosion is defined by PEO’s Mr (TFs 5–7), 
which is further increased by the addition of the drug and other excipients. The most sig-
nificant reduction in the gel layer thickness was observed in the lowest Mr PEO studied. 
On the other hand, the next two Mr PEOs had exhibited a significantly lower reduction of 
the gel layer thickness after the addition of excipients, showing that due to rigid interac-
tions among polymer molecules the gel is still strong and therefore robust to mechanical 
stress.
The different swelling kinetics of pure PEO tablets and PEO tablets with excipients are 
the result of the alteration of interactions between polymer chains (45), being more pro-
nounced in low-Mr PEOs. When highly soluble excipients are added into the formulation, 
the swelling/erosion rate changes (42). The presence of excipients broke the interactions 
and the chains started to unfold; erosion began and was synchronized with swelling, 
causing a constant gel layer thickness. Generally, during swelling, highly soluble excipi-
ents dissolve quickly before a tight gel layer is formed on the matrix surface. They absorb 
water and therefore help the medium penetrate into the inner matrix, leading to faster 
tablet hydration, and they accelerate initial swelling, which depends on the viscosity of the 
gel layer. Because PEG, drug, and other freely soluble excipients are added to the TFs, they 
significantly affect the formation of the gel layer, causing the same swelling rate but  increase 
erosion in formulations (1, 3).
Fig. 4. Drug release profiles (symbols) for TFs 5–7 measured: a) without medium flow; b) 12 mL 
min–1 flow rate; c) 64 mL min–1 flow rate; d) standard paddle method.
a)                                                                    b)
c)                                                                    d)
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Drug release from PEO PRT
Drug releases from TFs 5–7 were measured with no flow and at two different flow 
rates (12 and 64 mL min–1), as well as with the standard paddle method (Fig. 4). The drug 
release rates are significantly faster at higher flow rates, and the impact of the flow is more 
pronounced for the formulation containing the lowest Mr of PEO (TF 5 in Fig. 4a–c). The 
results show that drug release and its kinetics depend on the PEO Mr and mechanical 
stress applied to the matrix tablets.
Correlation between drug release kinetics and gel layer thickness
To evaluate the diffusion and erosion contribution to drug release, drug release pro-
files and gel thicknesses measured under the same conditions were fitted using Eqs. 1 and 
2, and the relative effect of diffusion and erosion mechanisms on drug release were deter-
mined using Eqs. 5 and 6, respectively. The parameters obtained by the fittings are pre-
sented in Table III and Fig. 5. Parameter A, which depends on the rate of chain relaxation 
and swelling (representing the diffusion impact on drug release), is independent of flow 
rate and PEO Mr, indicating that neither the flow rate nor polymer Mr change the polymer 
swelling. Parameter B, which describes the gel erosion, increases with increasing flow rate 
as well as with decreasing PEO Mr. The parameter , which depends on drug equilibrium 
volume fractions at gel-medium interface S (vdeq) and at glassy-gel interface R (vd*), also 
depends on PEO Mr and on flow rate. It increases with increasing mechanical stress for all 
relative molecular masses. When drug release and gel thicknesses were measured without 
the flow, veq was independent of Mr (Table III), confirmed also with dissolution data (Fig. 
4a). Under no mechanical stress, gel erosion is very small (i.e., only 1 %), and the main re-
lease mechanism is drug diffusion through the gel layer, which can also be seen from the 
diffusion and erosion contribution obtained by simultaneously fitting the gel thicknesses 
and drug releases during tablet hydration (Figs. 6a and 5b, Table III). Furthermore, a dif-
ference in gel layer thickness occurred between TF 5 formulations containing a lower PEO 
Mr (≈ 6 mm) and between TF 6 and 7, containing higher Mr (≈ 8 mm). Upon increased me-
chanical stress during tablet swelling, veq increased and became Mr-dependent; that is, it 
decreased with increasing Mr, confirming dynamic condition drug release results (Fig. 
4b–d). This demonstrates that, when the mechanical stress was absent, the equilibrium 
drug concentrations at swelling and erosion fronts were the same for all PEOs, but at 
higher shear forces the gel of PEO with lower Mr was weaker and it eroded faster, also 
causing higher drug concentration at the erosion front. The values of the delay time t0 
(Table III) were non-zero only at a flow rate of 12 mL min–1 (t0 = 1.6 h for TF 5, 1.1 h for TF 
6, and 1.0 h for TF 7) and at 64 mL min–1 flow in PEO tablets with the highest Mr (t0 = 0.7 h 
for TF 7). This implies that under such flow conditions large parts of the gel were detached 
from PRT-hydrated gels and a certain period of time was needed for the drug to diffuse or 
erode out of it. At 64 mL min–1 flow, the mechanical forces were strong enough that they 
broke the eroded medium- and low-Mr PEO gel so quickly that the delay time could not be 
detected. On the other hand, they were not strong enough for total erosion of the gel parts 
removed from the gel layer formed with the PEO with the highest Mr.
The relative contributions of diffusion and erosion mechanisms to drug release at dif-
ferent hydration times are shown in Figs. 5a,b. The results demonstrate that under no-flow 
conditions diffusion is the main release mechanism for all molecular masses at all time 
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points measured and correlates well with gel layer thickness under the same conditions 
(R2 = 0.91). At applied flow, the diffusion mechanism dominated drug release at the begin-
ning, but later the erosion mechanism prevailed in the lowest and medium-Mr PRTs (TFs 
5 and 6). The transition from diffusion-to erosion-dominated drug release occurred 1 h 
later when a flow rate of 12 mL min–1 was applied (Fig. 5b). In the tablets with the highest 
Mr (TF 7), the effect of 12 mL min–1 flow rate is insignificant compared to the static condi-
tion, and the diffusion mechanism dominates for the first 13 h. The effect of flow on erosion 
was observed at a flow rate of 64 mL min–1, at which the erosion mechanism prevailed at 
approximately 8 h. The dominant release mechanism depends on the gel layer properties. 
When the gel layer is tough enough to withstand mechanical stress, diffusion is predomi-
nant; in contrast, when the gel layer is weaker, erosion overcomes the diffusion mecha-
nism. The gel layer properties mostly depend on the polymer characteristics, mainly on its 
viscosity, concentration, and additives added, affecting the intrapolymer interactions (46).
Moreover, a good correlation was established between drug release profiles gained by 
the standard paddle method and gel thicknesses (R2 = 0.91), confirming previously  reported 
data that increased M forms a thicker and more robust gel layer, resistant to mechanical 
stresses.
A correlation between the previously reported network solution concentration (47) 
and the diffusion coefficient (A) under the no-flow condition was found (R2 = 0.95), con-
firming the formation of a robust gel at a lower concentration for a polymer with a higher 
Mr, for which diffusion makes a larger contribution to drug release. Moreover, a good cor-
relation (R2 = 0.96) between the erosion coefficient (B) and gel thickness under flow condi-
tions of 64 mL min–1 was also established, confirming that erosion is reduced with  increased 
gel layer thickness.







(mm h–1) veq t0 (h) kd (1/h
0.5) kr (1/h) kd/kr (h0.5)
TF 5
No flow 5.8 0.8 0.001 0.0 0.0015 0.0004 4.2
12 5.7 1.8 0.057 1.6 0.0960 0.0520 1.8
64 6.0 2.1 0.100 0.0 0.1700 0.1030 1.7
TF 6
No flow 6.0 0.5 0.001 0.0 0.0017 0.0002 7.2
12 5.8 1.4 0.022 1.1 0.0370 0.0160 2.3
64 6.0 1.6 0.070 0.0 0.1210 0.0570 2.1
TF 7
No flow 6.1 0.6 0.001 0.0 0.0014 0.0002 6.3
12 5.8 0.7 0.010 1.0 0.0170 0.0033 5.2
64 6.0 1.1 0.048 0.7 0.0800 0.0280 3.0
A – Fickian diffusion, B – erosion contribution, veq – medium equilibrium volume fractions at swelling interface, 
t0 – delay time, kd – diffusion rate constant, kr – erosion rate constant
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This conclusion is also supported by a good correlation between the reported rheo-
logical Young’s modulus (Er) (47) and B in the case of increased mechanical stress (R2 = 1.00 
for 12 mL min–1 and R2 = 0.98 for 64 mL min–1). This confirms that when a more viscous gel 
layer is formed (PEO with a higher Mr) the erosion is lower, leading to slower drug release 
mainly through diffusion.
At the same time, a good correlation (R2 > 0.95) was also established between gel thick-
ness determined at a flow rate of 64 mL min–1 and drug release under the same conditions 
in the first 5 h regardless of PEO Mr. After 5 h the correlation had decreased with time (Fig. 
5b) due to the predominant erosion mechanism, resulting in uncontrolled destruction of 
the gel layers. As a result, all three PEO tablets had disintegrated in at least 8 h, leading to 
a faster drug release (1, 2, 33, 40, 44). The same effect can also be gained with lower polymer 
concentrations in the matrix tablets (33, 48).
Fig. 5. a) Parameters A, B, and veq obtained by fitting the time dependencies of the gel layer thick-
nesses and drug release kinetics using Eqs. 1 and 2 for TF 5. TF 6, and TF 7 at different flow rates; 
b) the diffusion and erosion contributions to drug release determined from fitting parameters and 
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Estimation of the percolation threshold
Taking into consideration the percolation theory, different drug release behavior in 
relation to polymer concentration due to the formation of inherent gel layers is expected 
(16). In this study, initial binary systems of the model drug (BCS III) and PEO polymers 
with different Mr and different polymer ratio (% of polymer) were investigated (Table II). 
For medium- Mr PEO, a comparison between binary (TF Y10–Y30; Table II) and multicom-
ponent systems (TF 6; Table I) was also performed in order to understand the impact of the 
excipients (TF 6a; Table I) and tablet shape (TF 6b; Table I) on drug release (i.e., connected 
to its surface-to-volume ratio). It should be noted that drug solubility can affect drug re-
lease (16, 42, 44, 49), but because the same model drug (BCS III) was used for all selected 
binary systems (X, Y, Z) its solubility effect on drug release was the same in all cases, and 
therefore only the polymer Mr effect was observed.
During the research, 40 batches of tablets with different PEOs were prepared using up 
to 17 different polymer and model drug ratios ranging from 10 to 90 %. Only concentra-
tions near percolation thresholds are presented in detail here (Fig. 6 and Table IV).
Based on drug release profiles (Fig. 6), a significant change in the % of the released 
drug was observed between 16 and 18 % of the lowest Mr PEO concentration (TFs X, Fig. 
6a). For medium-Mr PEO (TFs Y, Fig. 6b), a change in release profiles was observed between 
Fig. 6. Drug release profiles using the paddle method from: a) binary systems (X10–X30) and multi-
component systems of low-Mr PEO with round (TF 5) and oval (TF 5b) tablet shapes; b) binary systems 
(Y10–Y30) and multicomponent systems with medium-Mr PEO with round (TF 6) and oval (TF 6b) 
tablet shapes; c) binary systems (Z10–Z30) and multicomponent systems with high-Mr PEO with 
round (TF 7) and oval (TF 7b) tablet shapes; and d) medium-Mr PEO tablets (TF 6, round and TF 6b, 
oval) with different proportions of PEO (TFs 6a–6c).
a)                                                          b)
c)                                                          d)
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15 and 16 % of polymer concentration. For the highest Mr PEO (TFs Z, Fig. 6c), a significant 
change in drug release profile was detected between 10 and 12 % of the polymer. Percola-
tion thresholds were set as follows: for low-Mr PEO at 18 % of polymer concentration, for 
medium-Mr PEO at 16 %, and for high-Mr PEO at 12 %. All set concentration thresholds are 
lower than previously estimated, confirming that the general recommendation (50) of 
more than 20 % PEO polymer in the matrix formulation is well set in the case of binary 
systems. 
To confirm the percolation thresholds of binary mixtures based on drug release 
 studies (Fig. 6), kinetic constants were also calculated using Eq. 7 and 8. The kinetic data 
(Table IV) confirmed the PEO percolation threshold concentrations. Above set percolation 
Table IV. Higuchi (kh) and Korsmeyer-Peppas (k) kinetic constants, with corresponding exponent m 
indicating the release mechanism, and determination coefficient (R2) of binary test formulations (TF) X, Y 
and Z and multicomponent TFs (TF 5, TF 6 and TF 7)
TF % PEO (m/m)
Higuchi equation Korsmeyer-Peppas equation
kh (% min−0.5) R2 k (% h−1) m R2
X10 10 1.902 0.67 17.376 0.324 0.86
X15 15 2.529 0.77 9.894 0.422 0.94
X16 16 2.767 0.85 8.857 0.431 0.96
X18 18 3.535 0.99 0.311 0.843 1.00
X20 20 3.502 0.99 0.229 0.890 1.00
X30 30 2.561 0.97 4.452 1.032 1.00
TF 5 27 4.722 0.80 1.291 0.693 0.99
Y10 10 2.026 0.72 21.504 0.285 0.92
Y15 15 2.933 0.91 8.440 0.437 0.97
Y16 16 4.446 1.00 0.748 0.779 0.99
Y18 18 3.537 0.99 3.069 0.536 0.98
Y20 20 2.878 0.96 0.654 0.702 0.98
Y30 30 2.558 0.90 0.141 0.904 0.96
TF 6 27 5.487 0.91 0.325 0.920 1.00
Z10 10 1.996 0.58 3.157 0.701 0.98
Z12 12 4.456 1.00 0.298 0.888 0.99
Z15 15 4.311 1.00 0.180 0.959 0.99
Z18 18 4.594 1.00 0.191 0.961 0.99
Z20 20 4.722 0.99 0.151 1.011 1.00
Z30 30 4.675 0.99 0.047 1.220 1.00
TF 7 27 6.041 0.99 0.284 0.978 0.99 
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thresholds, the drug release rate is controlled by diffusion through a fully hydrated gel 
layer. Diffusion was detected by a good fit of the drug release kinetics to the Higuchi equa-
tion (R2 ≥ 0.99). On the other hand, m values of the Korsmeyer-Peppas equation being close 
to 0.8 indicated anomalous diffusion (39). Below the percolation threshold, a sufficient gel 
layer is not formed, leading to uncontrolled drug release, resulting in a significant increase 
of the Korsmeyer-Peppas constant (k) (Table IV) for all selected PEOs.
The results thus show that the percolation threshold depends on the PEO Mr (R2 = 
1.00;). According to that, a good correlation (R2 = 0.98) was established between the previ-
ously determined concentrated network solution for selected PEOs (47) and the deter-
mined percolation threshold concentrations.
Gel layer robustness depends on PEO’s Mr and the start of the erosion process, which 
was also confirmed with a correlation study (R2 = 0.96) between the erosion coefficient (B) 
at 64 mL min–1 (Table III) and set percolation thresholds. The difference occurred due to 
different polymer characteristics. Different polymer Mr microstructures define their hy-
dration rate and viscosity, leading to differences in the velocity of drug release and faster 
drug release from the TFs with a lower Mr due to the formation of the softer gel layer.
It should be considered that, in addition to polymer concentration and its viscosity, 
polymer particle size distribution, excipients, drug concentration, and solubility (16) can 
also affect the percolation threshold. Because usually more than one excipient is used for 
the formation of PRTs, a binary system’s percolation threshold results should be inter-
preted carefully.
When comparing binary systems (TFs X-Z; Table II) with multicomponent systems 
(TFs 5–7; Table I) with the same size and shape, it can be concluded that for all multicom-
ponent TFs investigated anomalous drug release kinetics were detected (Korsmeyer- 
- Peppas 0.5 < m < 1; Table IV) as a result of drug diffusion and matrix erosion events. Drug 
release rates (Fig. 6a–c) from PEO TFs containing 27 % polymer (TF 5, 6, and 7) changed 
with the addition of water-soluble excipients compared to a binary system near the same 
polymer concentration (30 %) of the same PEO Mr,(TFs X–Z, Fig. 6).
To confirm the importance of well-set percolation thresholds, different medium-Mr 
PEO ratios (23, 27, and 35 %) in multicomponent formulations were evaluated (TFs 6a–6c; 
Table I). The similarity factor ( f2) between selected multicomponent formulations was cal-
culated using Eq. 9. Comparable drug release ( f2 = 52) for the TFs containing 23 % (TF 6a) 
and 27 % (TF 6b) of medium-Mr PEO can be found. On the other hand, drug release from 
a multicomponent system containing 35 % medium-Mr PEO (TF 6c; Fig. 6d) is significantly 
slower ( f2 = 34). These data show that the percolation threshold for the selected intermedi-
ate-Mr PEO multicomponent system is above 27 % and is much higher than in the binary 
system of the same PEO Mr (16 %). The results support the literature data that the addition 
of excipients enhances drug release (1, 3, 42, 44, 49) and significantly affect the polymer 
percolation threshold and that the proposed percolation threshold for PEO polymers of 20 
% (50) is too low in selected multicomponent PEO formulations. These results support the 
theory that the percolation threshold for multicomponent systems should be precisely 
determined during formulation development because the formation of a robust gel layer 
is crucial for ensuring controlled drug release (19). If the percolation threshold is not 
reached, the drug release from such PRTs can be uncontrolled and quite variable. More-
over, the outcome from dissolution results strengthens the research data that the gel layer 
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robustness can be increased with a higher polymer proportion, resulting in a more uni-
form gel layer and a better-controlled drug release (3, 43, 48).
When comparing multicomponent systems with the same mass and composition but 
with different shapes (TFs 5, 5b; 6, 6b; and 7, 7b), it was concluded that the shape of the 
tablet as well as the polymer proportion significantly (f2 < 50) affect the drug release  kinetics 
(Fig. 7). Drug release from a round tablet is faster than from an oval one due to its greater 
surface area, confirming the same literature data (51). These results indicate that the PEO 
concentration threshold differs between its Mr, formulation composition (Table I, Fig. 6a–d), 
and tablet shapes (Table I, Fig. 6a–c).
The results confirmed that percolation theory is directly connected to the polymer Mr, 
and composition and shape of a tablet. At the same time, they show that the percolation 
threshold for a binary system is not a good indicator of the percolation threshold of a 
 multicomponent system. Finally, they showed that the general proposed minimal critical 
PEO polymer concentration limit (20–30 %) (50, 52, 53) depends on several factors and 
should be well set during the development of PRTs.
Fig. 7. Overlays of: a) SAXS; b) WAXS profiles of PEO powders with low (1M), medium (2M), and high 
(4M) Mr; The plots of: c) percolation threshold (PT, circle) and the ratio of the heat of coalescence to 
the heat of fusion (QF, diamond) vs. surface fractal dimension (Ds) of different PEOs; d) Ds (square) 
and QF (the heat of coalescence to the heat of fusion*100) (triangle) vs. surface Mr of PEO.
a)                                                                              b)
c)                                                                              d)
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Therefore, it is crucial to consider all these factors during PRT development. Notably, 
higher polymer concentration must be applied in a multicomponent formulation in order 
to gain a robust PRT, ensuring controlled drug release compared to the binary system.
Relationship of PEO thermo-physical properties and nanostructure parameters to 
percolation threshold of drug loading
To better understand the difference between selected polymers at the molecular level, 
SAXS and WAXS analyses of the PEO powders were performed. Figs. 7a,b show the overlay 
of powder SAXS and WAXS profiles of three PEOs obtained at room temperature. Examin-
ing the SAXS profiles, samples with low and medium Mr show almost identical patterns, 
whereas the sample with a higher Mr differs significantly in the low-angle part, qualita-
tively indicating larger nanostructural features in the solid state. On the other hand, the 
identical Bragg peak positions in the WAXS patterns confirm the very similar crystal struc-
ture among all the selected PEOs. Furthermore, the relative peak intensities of the Bragg 
peaks with respect to the diffuse background of an amorphous halo (data not shown) re-
veal a comparable degree of crystallinity in the PEOs of different molecular masses, con-
firming prior data obtained through DSC or X-ray diffraction (47, 54).
The qualitative analysis of the SAXS patterns shows systematic differences between 
selected PEOs in the surface fractal dimension (Ds)s at the nanoscale (i.e., between 1 and 
100 nm). The Ds values were derived as the slope of the logarithmic plot of scattering in-
tensity versus the scattering vector (34). As seen in Fig. 7c, the SAXS-derived Ds values 
apparently correlate with the percolation threshold concentration of the composition- 
Fig. 8. An overlay of DSC thermograms of PEOs of selected molecular masses: a) low; b) medium; c) 
high. The micrographs at 40 and 120 °C are shown to illustrate the intactness of polymer particles 
beyond the melting point and below the flow transition temperature.
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- dependent change of the drug release profile of PEOs with different molecular masses. A 
correlation between fractal properties and percolation threshold has also been suggested 
in terms of permeability through the matrix network (55).
In Fig. 8, the thermograms of semi-crystalline PEOs of different molecular masses 
comprise the melting transition of crystalline fractions at 69 °C, which is in agreement with 
the range reported in the literature (56). The glass transitions of the amorphous fractions 
of PEO are reported between –50 and –57 °C (57). Therefore, the supercooled liquid phase 
of amorphous PEO fractions is embedded between the ensembles of the crystalline 
 domains. Interestingly, the thermograms show a small but distinct exothermic event at 
around 164–170 °C, which is 95–100 °C above the melting point. To our knowledge, such 
thermal transitions in PEOs have not been reported in the literature. Thermal microscopy 
of the PEO powders was used to visually observe the events related to this peculiar 
 thermal signature. As seen in the micrographs at 40 and 120 °C, PEO particles remain 
intact and uncoalesced even at a temperature much above the melting temperature. They 
were also more transparent (due to the melting of the crystalline fraction). However, 
 particles were observed to transiently coalesce across the temperature region of the 
 exotherm. This suggests that the exotherm represents the heat of coalescence, and the 
 corresponding temperature is attributable to the onset of the viscous flow transition of 
anisotropic melt to the isotropic phase. The ratios of the heat of coalescence to the heat of 
fusion (QF) for different PEOs are presented in Fig. 7d. From the plots, a clear correlation 
of Ds and QF was observed. The opposite relations of PT and QF to Ds suggest that the 
thermal plasticization propensity of the PEO structures can be considered analogously to 
the water-induced plasticization process during gel formation.
Finally, the qualitative differences between selected PEO polymers were detected 
 using thermal microscopy between 120 and 170 °C, confirming that the exothermic peak 
is related to the process of particle coalescence of fully X-ray amorphous grains, which is 
a unique feature for polymers with melt memory. Furthermore, the SAXS results defined 
differences between selected PEO polymers in Ds, indicating polymer complexity due to 
the corrugated nanostructure of the polymeric particle surfaces. This is possibly related to 
the difference in the extents and modes of lamellar folding for PEO crystals and the 
 embedded degree of heterogeneity of their amorphous states. Although not widely exploited 
so far for PEOs, it has been argued in the literature that Ds values correlate with the drug 
loading capacity in the nanoparticles based on PEG-PLA copolymer (58). Ma et al. recently 
reported an interesting study of the evolution of a fractal parameter obtained by SAXS 
during drug delivery from a silica-polymer based core-shell structure (59). Therefore, with 
increased polymer Mr, the surface roughness of polymer particles is lower, defining  higher 
resistance to diffusion and consequently lower drug release from such systems.
The results thus show that PRT characteristics depend on the polymer’s attributes, 
which are defined by its molecular nature. This study has, therefore, systematically indi-
cated how nanostructural differences of PEO polymers affect the final quality of PRTs. It 
shows that the differences in nanostructure between PEO polymers with different Mr 
 define their characteristics during swelling, a feature additionally quantified by MRI. With 
several fundamental correlations, it shows that understanding PEO polymer properties at 
the molecular (nanostructural) level can be a good way to predict the final formulation 
behavior. This study managed to connect data at the molecular level so that is applicable 
to data at the bulk level. The data thus show that from molecular level polymer character-
istics it is possible to predict formulation behavior at the bulk level.
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CONCLUSIONS
This study presents a structured and detailed insight into the behavior of PEO polymers 
at different levels. Differences observed at the microstructural level (SAXS and thermal ana-
lysis) between different PEO molecular masses are reflected at the macroscopic level (MRI 
analysis), resulting in Mr-dependent hydration rate as well as the gel consistency. The thickest 
and strongest gel is formed in the matrix formulation composed of PEO with the highest Mr. 
The systematic evaluation of mechanical stresses’ impact on gel thickness during tablet swell-
ing showed that differences depend on the PEO molecular masses. SAXS detected the differ-
ence in nanostructure between the high Mr PEO and the other two PEOs. The ratio of the heat 
of coalescence to the heat of fusion for different PEOs obtained through DSC correlated with 
the polymer nanoscale surface fractal dimension, representing a novel approach to qualita-
tive separation of PEO polymers with different molecular masses. According to differences 
in the nanoscale surface dimension, the diffusion rate in high-Mr PEO is smaller compared to 
PEOs with a lower Mr, explaining the differences in their drug release rates.
The diffusion and erosion contributions to drug release were calculated in order to 
confirm the experimental results. This showed that under no-flow conditions the main 
release mechanism for all selected PEOs through the gel layer is drug diffusion. Under 
mechanical stress, the diffusion mechanism dominates at the beginning, but later the ero-
sion mechanism prevails, showing higher resistance in higher Mr PEO.
Several good correlations between results gained at the molecular, film, and bulk 
levels were established. Based on the correlations obtained, it can be assumed that the 
drug release rate depends on gel thickness (R2 = 0.91) and is closely connected to the ero-
sion coefficient (B) (R2 = 0.96) and polymer) rheological characteristics.
For selected PEO Mr binary systems, the percolation thresholds were set to 12 % for 
high, to 16 % for medium, and to 18 % for low Mr PEOs. Furthermore, the addition of water-
soluble excipients and increased tablets’ surface area raised the percolation threshold con-
centration above 27 % in the medium Mr PEO. As an innovative approach for percolation 
threshold prediction, a good correlation (R2 = 0.98) between the reported concentrated 
network solutions and set binary percolation thresholds was established.
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